Hoekman John 4
4 · IMPEL NEUROPHARMA INC · Filed Dec 23, 2021
Insider Transaction Report
Form 4
Hoekman John
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-12-22+20,000→ 0 totalExercise: $1.64Exp: 2021-12-22→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-12-22$1.64/sh+20,000$32,800→ 128,221 total
Footnotes (1)
- [F1]The option is 100% vested and exercisable.